Denis Chem Lab Ltd Stock Price Today (NSE: DENISCHEM)
Fundamental Score
Denis Chem Lab Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Denis Chem Lab Ltd share price today is ₹68.85, down 1.22% on NSE/BSE as of 3 August 2026. Denis Chem Lab Ltd (DENISCHEM) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹98.09 (Cr). The 52-week high for DENISCHEM share price is ₹103.00 and the 52-week low is ₹56.10. At a P/E ratio of 11.66x, DENISCHEM is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 9.52% and a debt-to-equity ratio of 0.05.
Denis Chem Lab Ltd Share Price Chart — NSE/BSE Historical Performance
Denis Chem Lab Ltd share price chart: -4.58% return over the past month. 52-week high ₹103.00, 52-week low ₹56.10.
Denis Chem Lab Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹70.50 | ₹71.49 | ₹68.60 | ₹68.85 | 35.27K (Cr) | |
| ₹70.99 | ₹71.85 | ₹69.50 | ₹70.24 | 3.12K (Cr) | |
| ₹69.13 | ₹71.00 | ₹69.13 | ₹69.70 | 25.13K (Cr) | |
| ₹71.79 | ₹71.79 | ₹69.35 | ₹69.67 | 16.57K (Cr) | |
| ₹70.50 | ₹71.80 | ₹70.01 | ₹70.08 | 9.26K (Cr) | |
| ₹72.19 | ₹72.19 | ₹70.13 | ₹71.00 | 4.40K (Cr) | |
| ₹71.30 | ₹71.35 | ₹68.00 | ₹69.79 | 33.13K (Cr) | |
| ₹71.39 | ₹71.39 | ₹70.17 | ₹71.33 | 794.00 (Cr) | |
| ₹72.39 | ₹73.85 | ₹70.31 | ₹70.84 | 72.44K (Cr) | |
| ₹71.76 | ₹72.19 | ₹68.55 | ₹70.00 | 5.50K (Cr) |
Denis Chem Lab Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹70.50 | ₹71.49 | ₹68.60 | ₹68.85 | -2.34% | |
| ₹74.90 | ₹91.00 | ₹68.00 | ₹70.24 | -6.22% | |
| ₹73.45 | ₹76.98 | ₹68.40 | ₹74.85 | +1.91% | |
| ₹79.80 | ₹82.80 | ₹68.35 | ₹73.00 | -8.52% | |
| ₹59.90 | ₹85.70 | ₹58.51 | ₹78.38 | +30.85% | |
| ₹75.00 | ₹76.01 | ₹56.10 | ₹56.54 | -24.61% | |
| ₹79.00 | ₹84.81 | ₹73.30 | ₹76.86 | -2.71% | |
| ₹79.70 | ₹86.85 | ₹72.35 | ₹77.99 | -2.15% | |
| ₹85.01 | ₹87.95 | ₹76.00 | ₹78.48 | -7.68% | |
| ₹91.10 | ₹93.00 | ₹82.75 | ₹87.85 | -3.57% | |
| ₹96.40 | ₹97.35 | ₹86.00 | ₹91.67 | -4.91% | |
| ₹94.80 | ₹103.00 | ₹92.00 | ₹94.94 | +0.15% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Micro-cap pharma play with promoter shenanigans and liquidity trap written all over it.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Denis Chem Lab's stock has been under pressure, hitting a 52-week low of on March 30, 2026. The Daga group increased their stake to 9.64% on March 27, 2026, acquiring 2,67,499 shares, representing a 1.93% stake, in an off-market transaction. Trading window closed on April 1, 2026, ahead of FY26 results.
CORE STORY (THE REAL GAME)
Micro-cap pharma play vulnerable to promoter action and liquidity risk. Not a growth story, but a potential value unlock if management executes.
- Daga group increased stake to 9.64%
- Q3 FY26 net profit increased 88.6% YoY
- Stock trading near 52-week low
- Positive FY26 results
- New order wins
- Strategic acquisition
- Micro-cap liquidity risk
- Promoter action uncertainty
- Negative news sentiment
Daga group increasing stake, but unclear if value accretive.
Indian pharma sector projected to reach $130 billion by 2030, but faces pricing pressures.
Free Cash Flow 5Y: ₹44.9 Cr, profit converting to cash.
Near-term depends on FY26 results. Long-term hinges on management execution and sector growth.
Primary Thesis Risk
Promoter value extraction leading to shareholder wealth destruction.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Denis Chem Lab Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Denis Chem Lab Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DENISCHEM across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Attractive Valuation (P/E: 11.66 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Excellent EPS Growth (30.06% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (30.06% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (15.15x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹38.14 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Below-Average Return on Equity (9.52%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-43.66%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Denis Chem Lab Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Denis Chem Lab Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Denis Chem Lab LtdDenis Chem Lab ...Selected✓ DENISCHEM • 537536 | 47.9/100 | ₹68.85₹69 | ₹98.09₹98.09 | 11.66Average 11.7 Average | 9.52%Poor 9.52% Poor | 14.01%Average 14.01% Average | 0.05Excellent 0.1 Excellent | 30.06%Excellent 30.06% Excellent | 10.81%Good 10.81% Good | 2.12% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Denis Chem Lab Ltd PE Ratio History
Historical price-to-earnings ratio for DENISCHEM — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹8.04 | ₹167.50 | 20.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Denis Chem Lab Ltd Dividend History
Annual cash dividends paid by DENISCHEM — dividend yield 2.12%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.47 Cr |
| FY 2024 | ₹2.78 Cr |
| FY 2023 | ₹2.08 Cr |
| FY 2022 | ₹1.04 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Denis Chem Lab Ltd Quarterly Performance
Latest quarterly metrics for DENISCHEM — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
12.98%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-43.66%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
10.81%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
30.06%
Compounded annual net profit growth over 5 years
Denis Chem Lab Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for DENISCHEM — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Denis Chem Lab Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Denis Chem Lab Ltd (DENISCHEM) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Denis Chem Lab Ltd
About DENISCHEM (Denis Chem Lab Ltd)
Denis Chem Lab Ltd is a pioneering force within the Indian pharmaceutical landscape, dedicated to the meticulous creation and distribution of sterile intravenous injectable solutio...ns for both human and animal healthcare needs. The company operates with a singular focus: to produce high-quality, life-saving medications delivered directly into the bloodstream. Their commitment extends beyond simply manufacturing; it embodies a dedication to precision, sterility, and efficacy, ensuring that each product meets the rigorous demands of modern medicine. From bustling urban hospitals to rural veterinary clinics, Denis Chem Lab aims to be a trusted provider of critical injectable therapies. The company’s diverse portfolio includes a spectrum of essential injectable medications, ranging from potent antibiotic treatments designed to combat severe infections, to carefully formulated diuretic solutions for fluid management. They also produce parenteral amino acid formulations to nourish patients unable to receive nutrition through conventional means, alongside plasma volume expanders crucial in emergency situations. Further strengthening their product line are specialized anti-anaerobic injections, fever-reducing anti-pyretic solutions, and sterile irrigation and dialysis fluids, all contributing to a comprehensive offering for a wide array of medical conditions. Each product is developed with scientific rigor and manufactured in state-of-the-art facilities. Beyond their own brand, Denis Chem Lab also extends their expertise to other pharmaceutical companies through contract manufacturing services. This collaborative approach leverages their advanced manufacturing capabilities and stringent quality control processes to support the broader healthcare industry. By partnering with third parties, Denis Chem Lab contributes to increasing the availability of vital medications, fostering innovation, and upholding the highest standards of pharmaceutical production. This dual focus – developing their own product line and providing contract manufacturing services – positions Denis Chem Lab as a versatile and reliable player in the pharmaceutical sector.
Company Details
Key Leadership
Corporate Events
Latest News
DENISCHEM Share Price: Frequently Asked Questions
What is the current share price of Denis Chem Lab Ltd?
Denis Chem Lab Ltd (DENISCHEM) trades at ₹68.85 on NSE and BSE. Market cap ₹98.09 (Cr). Educational data only.
What is the P/E ratio of Denis Chem Lab Ltd?
Denis Chem Lab Ltd has a P/E of 11.66x vs industry average 34.89x.
What is the Bull Run score for Denis Chem Lab Ltd?
Denis Chem Lab Ltd has a Bull Run score of 47.9/100 based on 25+ financial parameters.
Does Denis Chem Lab Ltd pay dividends?
Denis Chem Lab Ltd has a dividend yield of 2.12%. Past dividends don't guarantee future payments.
What is the ROE of Denis Chem Lab Ltd?
Denis Chem Lab Ltd has ROE of 9.52%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Denis Chem Lab Ltd?
Denis Chem Lab Ltd has debt-to-equity of 0.05.
Is Denis Chem Lab Ltd a good investment?
Bull Run gives Denis Chem Lab Ltd a score of 47.9/100. This is not investment advice — consult a SEBI-registered advisor.